Zora Biosciences Diagnostic Portfolio

Zora Diagnostic Portfolio

Zora Diagnostic Portfolio currently includes two tests:
- CERT: Coronary Event Risk Test
- OCDT: Ovarian Cancer Diagnostic Test

Portfolio overview

CERT - Coronary Event Risk Test

CERT is a blood based diagnostic test that identifies patients who are at risk of heart attack or cardiovascular death. CERT helps to find high-risk patients even if their other clinical parameters such as LDL-C might suggest that they are not at an elevated risk.

OCDT - Ovarian Cancer Diagnostic Test

Ovarian cancer is the eighth most frequent cause of cancer death among women. We are developing diagnostic test that can diagnose the most common type of ovarian cancer already in the early stage.